Goodwill and Intangible Assets, Net

9 Months Ended

Sep. 30, 2014

Goodwill and Intangible Assets Disclosure [Abstract]

The changes in the carrying amount of goodwill for the nine months ended September 30, 2014 are as follows:



Balance as of December 31, 2013	$	13,823
Acquisitions	84,955
Balance as of September 30, 2014	$	98,778

No goodwill or accumulated impairment losses existed as of September 30, 2014 and December 31, 2013.

Intangible assets consist of the following at September 30, 2014:



	Gross Carrying Amount		Accumulated Amortization			Net
Patents, related technologies and know-how	$	41,872	$	(9,930	)	$	31,942
Customer relationships	11,100		(331		)	10,769
Trademarks	5,900		(119		)	5,781
In-process research and development	19,724		—			19,724
Total	$	78,596	$	(10,380	)	$	68,216

No in-process research and development or accumulated impairment losses existed as of September 30, 2014.

Intangible assets consist of the following at December 31, 2013:



	Gross Carrying Amount		Accumulated Amortization			Net
Patents, related technologies and know-how	$	34,772	$	(7,716	)	$	27,056
In-process research and development	14,900		—			14,900
Total	$	49,672	$	(7,716	)	$	41,956

No in-process research and development or accumulated impairment losses existed as of December 31, 2013.

Amortization expense was $1,290 and $709 for the three months ended September 30, 2014 and 2013, respectively, and $2,664 and $2,143 for the nine months ended September 30, 2014 and 2013, respectively. At September 30, 2014, the weighted average useful life for patents, related technologies and know-how; customer relationships; and trademarks was 10.3 years.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details